• References

    1. OHalloran DJ, Shalet SM. Radiotherapy for pituitary adenomas: An endocrinologist’s perspective. Clin Oncol 1996;8:79-84
    2. Nobels FE, Kwekkeboom DJ, Herder WW de, et al. Klinisch niet-functionerende hypofyseadenomen; diagnostische mogelijkheden en therapeutische opties. [Clinically non-functioning hypophyseal adenomas; Diagnostic possibilities and therapeutic options]. Ned Tijdschr Geneeskd 1992;136:1148-1152
    3. Sassolas G, Trouillas J, Treluyer C, et al. Management of nonfunctioning pituitary adenomas. Acta Endocrinol (Copenh) 1993;129(Suppl.):121-126
    4. Rauhut F, Stuschke M, Sack H, Stolke D. Volume dependence of late effects after radiotherapy of invasive pituitary adenomas. In: Wiegel T, Hinkelbein W, Brock M, Hoell T, editors. Controversies in Neuro-oncology. Frontiers of radiation therapy and oncology. Basel: Karger;1999. p. 315-317
    5. Gittoes NJL, Bates AS, Tse W, et al. Radiotherapy for non-functioning pituitary tumours. Clin Endocrinol 1998;48:331-337
    6. Paek SH, Beverly Downes M, Bednarz G, et al. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys 2005;61:795-808
    7. Snyder PJ, Fowble BF, Schatz NJ, et al. Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 1986;81:457-462
    8. van den Bergh ACM , Schoorl MA, Dullaart RP, et al. Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma. J Neuroophthalmol 2004;24:200-205
    9. Flickinger JC, Nelson PB, Taylor F, Robinson A. Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 1989;63:2404-2408
    10. Brada M, Burchell L, Ashley S, Traish D. The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 1999;45:693-698
    11. Brada M, Ashley S, Ford D, et al. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol 2002;57:713-717
    12. Erfurth E, Bulow B, Svahn-Tapper G, et al. Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J Clin Endocrinol Metab 2002;87:4892-4899
    13. Erfurth E, Hagmar L. Cerebrovascular disease in patients with pituitary tumors. Trends in Endocrinol and Metab 2005;16:334-342
    14. Erfurth E, Bulow B, Mikoczy Z, et al. Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour? Clin Endocrinol 2001;55:613-616
    15. Minniti G, Traish d, Ashley S, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma: Update after further 10 years. J Clin Endocrinol Metab 2004;90:800-804

    16. ICRU Prescribing, recording and reporting photon beam therapy. Report 50 1993, Bethesda, MD, USA.
    17. Tjeerdsma G, Sluiter WJ, Hew JM, et al. Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma. Eur J Endocr 1996;135:299-308
    18. Dullaart RP, Pasterkamp SH, Beentjes JA, Sluiter WJ. Evaluation of adrenal function in patients with hypothalamic and pituitary disorders; comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test. Clin Endocrinol 1999;50:465-471.
    19. Links TP, Tol KM van, Jager PL, et al. Life expectancy in differentiated thyroid cancer: A novel approach to survival analysis. Endocr Relat Cancer 2005;12:273-280
    20. Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 1993;38:571-578
    21. Breen P, Flickinger JC, Kondziolka D, Martinez AJ.. Radiotherapy for nonfunctional pituitary adenoma: Analysis of long-term tumor control. J Neurosurg 1998;89:933-938
    22. Chun M, Masko B, Hetelekidis S. Radiotherapy in the treatment of pituitary adenomas. Int J Radiat Oncol Biol Phys 1988;5:305-309
    23. Sheline GE. Proceedings:Treatment of nonfunctioning chromophobe adenomas of the pituitary. Am J Roentgenol Radium Ther Nucl Med 1974;120:553-561
    24. Jaffrain-Rea ML, Derome P, Bataini JP, et al. Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970-1988). Eur J Med 1993;2:398-403
    25. Park P, Chandler WF, Barkan AL, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 2004;55:100-107
    26. Woollons AS, Hunn MK, Rajapakse YR, et al. Non-functioning pituitary adenomas: Indications for postoperative radiotherapy. Clin Endocrinol 2000;53:713-717
    27. Soto-Ares G, Cortet-Rudelli C, Assaker R, et al. MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas. Eur J Endocrinol 2002;146:179-186
    28. Benveniste RJ, King WA, Walsh J, et al. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg 2005;102:1004-1012
    29. Andrewes DG, Kaye A, Murphy M, et al. Emotional and social dysfunction in patients following surgical treatment for brain tumour. J Clin Neurosc 2003;10:428-433
    30. Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol 1994;41:511-516
    31. Rosen T, Bengtsson B. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288.

    32. Guinan EM, Lowy C, Stanhope N, et al. Cognitive effects of pituitary tumours and their treatments: Two case studies and an investigation of 90 patients. J Neurol Neurosurg Psych 1998;65:870-876
    33. Peace KA, Orme SM, Padayatty SJ, et al. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin Endocrinol 1998;49:391-396.
    34. Noad R, Narayanan KR, Howlett T, et al. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clin Oncol 2004;16:233-237
    35. Wallymahmed ME, Foy P, MacFarlane IA. The quality of life of adults with growth hormone deficiency: Comparison with diabetic patients and control subjects. Clin Endocrinol 1999;51:333-338
    36. Perks JR, Jalali R, Cosgrove VP, et al. Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. Int J Radiat Oncol Biol Phys 1999;45:507-513
    37. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997;46:75-81
    38. Nilsson B, Gustavsson-Kadaka E, Bengtsson B, Jonsson B. Pituitary adenomas in Sweden between 1958 and 1991: Incidence, survival and mortality. J Clin Endocrinol Metab 2000;85:1420-1425
    39. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. Lancet 2001;357:425-431
    40. Bates AS, Bullivant B, Sheppard MC, Stewart PM. Life expectancy following surgery for pituitary tumours. Clin Endocrinol 1999;50:315-319

Leave a Reply

You must be logged in to post a comment.